Skip to main content
. 2022 Jun 20;27(12):3940. doi: 10.3390/molecules27123940

Figure 10.

Figure 10

Statistical analysis of viable, necrotic, and apoptotic HepG2 cells with CUR (A) or CUR@IRMOF-10 (B)—**** p < 0.0001 vs. control. Apoptosis assays for HepG2 cells after treatment with CUR (C) or CUR@IRMOF-10 (D).